Oma Savings Bank Plc: Manager´s Transactions – Jarmo Salmi
OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE, 2 MAY 2024 14.30 P.M. EET, MANAGER’S TRANSACTION
Oma Savings Bank Plc: Manager´s Transactions – Jarmo Salmi
Person subject to the notification requirements:
Name: Jarmo Salmi
Position: Member of the Board/Deputy Member
Issuer: Oma Savings Bank Plc
LEI: 743700LE1ECAPXC5UT18
Notification type: INITIAL NOTIFICATION
Reference number: 60910/5/4
Transaction date: 2024-05-02
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: ACQUISITION
Instrument type: SHARE
ISIN: FI4000306733
Transaction details
(1): Volume: 24 Unit price: 17.12 EUR
(2): Volume: 176 Unit price: 17.14 EUR
Aggregated transactions
(1): Volume: 200 Volume weighted average price: 17.1376 EUR
Oma Savings Bank Plc
Further enquiries:
Minna Sillanpää, CCO, tel. +358 50 66592
Distribution:
Nasdaq Helsinki Ltd
Major media
www.omasp.fi
OmaSp is the fastest growing in the Nordic countries and Finland’s most profitable bank. About 500 professionals provide nationwide services through OmaSp’s 45 branch offices and digital service channels to over 200,000 private and corporate customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediated products include credit, investment and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp core idea is to provide personal service and to be local and close to its customers, both in digital and traditional channels. OmaSp strives to offer premium level customer experience through personal service and easy accessibility. In addition, the development of the operations and services is customer-oriented. The personnel is committed and OmaSp seeks to support their career development with versatile tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Suspended trading due to national holiday17.5.2024 08:01:00 CEST | Press release
Lysaker, 17 May 2024 The below funds are suspended from the live trading on Nasdaq Copenhagen for Friday 17th May due to national holiday in Norway. As noted in the Financial Calender, the funds may not be available for trading on 1st May and 17th May due to official holidays affecting the Management Company's staffing. The share classes will resume trading on Tuesday 21st May. Regards Storebrand Asset Management AS Contacts: Kim Toftegaard Andreassen, Director, Kim.Toftegaard.Andreassen@storebrand.com Frode Aasen, Product Manager, fdc@storebrand.com Fund name and share classSymbolISINSKAGEN Focus ASKIFOANO0010735129SKAGEN Global ASKIGLONO0008004009SKAGEN Kon-Tiki ASKIKONNO0010140502SKAGEN m2 ASKIM2NO0010657356SKAGEN Vekst ASKIVEKNO0008000445Storebrand Indeks – Alle Markeder A5STIIAMNO0010841588Storebrand Indeks – Nye Markeder A5STIINMNO0010841570Storebrand Global ESG Plus A5STIGEPNO0010841604Storebrand Global Solutions A5STIGSNO0010841612Storebrand Global Multifactor A5STIGMNO00108415
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission Electron Microscopy Laboratory from the Swedish Medical Products Agency17.5.2024 08:00:00 CEST | Press release
STOCKHOLM, Sweden, May 17, 2024 (GLOBE NEWSWIRE) -- QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality Control Laboratories issued by the Swedish Medical Products Agency (Läkemedelsverket). QuTEM is thereby authorized to perform critical quality control analysis essential for the release of medicines to the market. The GMP Certificates and Manufacturing Permits cover medicinal and investigational medicinal products for both human and veterinary use. GMP regulations are formal standards established by regulatory bodies worldwide to ensure the quality, safety, and efficacy of pharmaceutical products. Manufacturing Permits for Independent Quality Control Laboratories are granted by the Swedish regulatory authority since January 2024 to laboratories that conduct tests directly impacting the releas
Teckningskurs för nyttjande av teckningsoptioner av serie TO7 i Terranet AB har fastställts till 0,073 SEK per aktie av serie B. Teckningsperioden inleds på måndag, den 20 maj 2024.17.5.2024 08:00:00 CEST | Pressemelding
Terranet AB (publ) (”Terranet” eller ”Bolaget”) emitterade 182 664 660 teckningsoptioner av serie TO7 i samband med Bolagets företrädesemission under det andra kvartalet 2023. Varje teckningsoption ger rätt att teckna en (1) ny B-aktie i Bolaget. Teckningskursen för teckningsoptionerna av serie TO7 ska fastställas till 70 procent av den volymvägda genomsnittskursen i Bolagets aktie på Nasdaq First North Premier Growth Market under mätperioden från och med den 2 maj 2024 till och med den 16 maj 2024, dock inte lägre än kvotvärdet för Bolagets aktier och inte högre än 0,27 SEK per aktie. Den volymvägda genomsnittskursen i Bolagets aktie uppgick under mätperioden till 0,104 SEK och således har teckningskursen fastställts till 0,073 SEK. Investerat belopp avrundas uppåt till två decimaler. Teckning av aktier med stöd av teckningsoptioner av serie TO7 pågår från och med den 20 maj 2024 till och med den 3 juni 2024. Fullständiga villkor för teckningsoptionerna finns att tillgå på Bolagets we
The subscription price for exercise of warrants of series TO7 in Terranet AB has been set to SEK 0.073 per share of series B. The exercise period begins on Monday, May 20, 2024.17.5.2024 08:00:00 CEST | Press release
Terranet AB (publ) (” Terranet” or the” Company”) issued 182 664 660 warrants of series TO7 in connection with the Company’s rights issue in the second quarter of 2023. Each warrant gives the right to subscribe for one (1) new share of series B in the Company. The subscription price for the warrants of series TO7 shall correspond to 70 percent of the volume weighted average price of the Company´s share on Nasdaq First North Premier Growth Market during the measurement period from and including the May 2, 2024, up until and including the May 16, 2024. However, not lower than the nominal value of the Company's share, and not higher than SEK 0.27 per share. The volume-weighted average price of the Company's share of series B during the measurement period amounted to approximately SEK 0.104. Thus, the subscription price has been determined to SEK 0.073. The invested amount must be rounded up to two decimals. The exercise period for warrants of series TO7 runs from May 20, 2024, up until an
First quarter 2024 results: SCOR starts 2024 with a strong first three-months net income of EUR 196 million17.5.2024 07:30:54 CEST | Press release
Press release 17 May 2024 - N° 07 First quarter 2024 results SCOR starts 2024 with a strong first three-months net income of EUR 196 million Group net income of EUR 196 million in Q1 2024 (EUR 176 million adjusted1) Group Economic Value2 under IFRS 17 of EUR 9.6 billion as of 31 March 2024, up +4.8%3 (+4.1% at constant economics3,4) compared with 31 December 2023, implying an Economic Value per share of EUR 54 (vs. EUR 51 as of 31 December 2023) Estimated Group solvency ratio of 215%5 as of 31 March 2024Annualized Return on Equity of 17.3% (15.5% adjusted1) in Q1 2024 Insurance revenue of EUR 4,113 million in Q1 2024 (+6.0%6 compared to Q1 2023)P&C combined ratio of 87.1% in Q1 2024 (+1.9pts compared to Q1 2023)L&H insurance service result7 of EUR 72 million in Q1 2024 (EUR -200 million compared to Q1 2023) Investments regular income yield of 3.5% in Q1 2024 (+0.7pts compared to Q1 2023) SCOR SE’s Board of Directors met on 16 May 2024, under the chairmanship of Fabrice Brégier, to appr